Tort-Merino Adrià, Falgàs Neus, Allen Isabel E, Balasa Mircea, Olives Jaume, Contador José, Castellví Magdalena, Juncà-Parella Jordi, Guillén Núria, Borrego-Écija Sergi, Bosch Bea, Fernández-Villullas Guadalupe, Ramos-Campoy Oscar, Antonell Anna, Rami Lorena, Sánchez-Valle Raquel, Lladó Albert
Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació Clínic per a la Recerca Biomèdica, University of Barcelona, Barcelona, Spain.
Department of Neurology & Neurological Sciences, University of California, San Francisco, California, USA.
Ann Clin Transl Neurol. 2022 Dec;9(12):1962-1973. doi: 10.1002/acn3.51689. Epub 2022 Nov 17.
Early- and late-onset Alzheimer's disease (EOAD and LOAD) share the same neuropathological traits but show distinct cognitive features. We aimed to explore baseline and longitudinal outcomes of global and domain-specific cognitive function in a well characterized cohort of patients with a biomarker-based diagnosis.
In this retrospective cohort study, 195 participants were included and classified according to their age, clinical status, and CSF AD biomarker profile: 89 EOAD, 37 LOAD, 46 young healthy controls (age ≤ 65 years), and 23 old healthy controls (>65 years). All subjects underwent clinical and neuropsychological assessment, neuroimaging, APOE genotyping and lumbar puncture.
We found distinct neuropsychological profiles between EOAD and LOAD at the time of diagnosis. Both groups showed similar performances on memory and language domains, but the EOAD patients displayed worsened deficits in visual perception, praxis, and executive tasks (p < 0.05). Longitudinally, cognitive decline in EOAD was more pronounced than LOAD in the global outcomes at the expense of these non-amnestic domains. We found that years of education significantly influenced the decline in most of the neuropsychological tests. Besides, the APOE ε4 status showed a significant effect on the decline of memory-related tasks within the EOAD cohort (p < 0.05).
Age of onset is a main factor shaping the cognitive trajectories in AD patients, with younger age driving to a steeper decline of the non-memory domains. Years of education are related to a transversal decline in all cognitive domains and APOE ε4 status to a specific decline in memory performance in EOAD.
早发型和晚发型阿尔茨海默病(EOAD和LOAD)具有相同的神经病理学特征,但表现出不同的认知特征。我们旨在探讨一个具有明确生物标志物诊断的患者队列中,整体及特定领域认知功能的基线和纵向结果。
在这项回顾性队列研究中,纳入了195名参与者,并根据他们的年龄、临床状态和脑脊液AD生物标志物谱进行分类:89例EOAD患者、37例LOAD患者、46例年轻健康对照者(年龄≤65岁)和23例老年健康对照者(年龄>65岁)。所有受试者均接受了临床和神经心理学评估、神经影像学检查、APOE基因分型和腰椎穿刺。
我们发现在诊断时,EOAD和LOAD之间存在不同的神经心理学特征。两组在记忆和语言领域表现相似,但EOAD患者在视觉感知、实践和执行任务方面表现出更严重的缺陷(p<0.05)。纵向来看,在整体结果中,EOAD的认知衰退比LOAD更明显,且主要体现在这些非遗忘领域。我们发现受教育年限对大多数神经心理学测试的衰退有显著影响。此外,APOE ε4状态对EOAD队列中与记忆相关任务的衰退有显著影响(p<0.05)。
发病年龄是影响AD患者认知轨迹的主要因素,发病年龄越小,非记忆领域的衰退越陡峭。受教育年限与所有认知领域的横向衰退有关,而APOE ε4状态与EOAD患者记忆表现的特定衰退有关。